107 related articles for article (PubMed ID: 17885359)
1. Rhabdomyosarcoma with widespread bone marrow infiltration: beneficial management role of F-18 FDG PET.
Seshadri N; Wright P; Balan KK
Clin Nucl Med; 2007 Oct; 32(10):787-9. PubMed ID: 17885359
[TBL] [Abstract][Full Text] [Related]
2. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
[TBL] [Abstract][Full Text] [Related]
3. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
4. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H
Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396
[TBL] [Abstract][Full Text] [Related]
5. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin.
Blodgett TM; Ames JT; Torok FS; McCook BM; Meltzer CC
Clin Nucl Med; 2004 Mar; 29(3):161-3. PubMed ID: 15162984
[TBL] [Abstract][Full Text] [Related]
6. Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities.
Ben Arush MW; Bar Shalom R; Postovsky S; Militianu D; Haimi M; Zaidman I; Israel O
J Pediatr Hematol Oncol; 2006 Jul; 28(7):440-5. PubMed ID: 16825990
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Yang J; Zhen L; Zhuang H
Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
9. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
10. Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.
Trout AT; Sharp SE; Turpin BK; Zhang B; Gelfand MJ
Pediatr Radiol; 2015 Jul; 45(7):1001-6. PubMed ID: 25646737
[TBL] [Abstract][Full Text] [Related]
11. The role of
Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.
Nihashi T; Hayasaka K; Itou T; Sobajima T; Kato R; Ito K; Ito Y; Ishigaki T; Naganawa S
Radiat Med; 2007 Apr; 25(3):130-4. PubMed ID: 17450338
[TBL] [Abstract][Full Text] [Related]
13. Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia.
Imataki O; Uemura M; Uchida S; Yokokura S; Takeuchi A; Ishikawa R; Kondo A; Seo K; Kadowaki N
Diagn Pathol; 2017 Nov; 12(1):77. PubMed ID: 29096655
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Paolini R; Bianchini E; D'Andrea E; Al-Nahhas A; Banti E; Muzzio PC; Rubello D
Nucl Med Rev Cent East Eur; 2007; 10(1):23-5. PubMed ID: 17694498
[TBL] [Abstract][Full Text] [Related]
15. Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography.
Kato T; Tsukamoto E; Nishioka T; Yamazaki A; Shirato H; Kobayashi S; Asaka M; Imamura M; Tamaki N
Clin Nucl Med; 2000 Nov; 25(11):870-3. PubMed ID: 11079582
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
Iagaru A; Goris ML
Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1746. PubMed ID: 18648808
[No Abstract] [Full Text] [Related]
17. Correlations between 18F-FDG uptake by bone marrow and hematological parameters: measurements by PET/CT.
Murata Y; Kubota K; Yukihiro M; Ito K; Watanabe H; Shibuya H
Nucl Med Biol; 2006 Nov; 33(8):999-1004. PubMed ID: 17127173
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
19. FDG PET in epithelioid hemangioendothelioma.
Rest CC; Botton E; Robinet G; Conan-Charlet V; Bizais Y; Visvikis D
Clin Nucl Med; 2004 Dec; 29(12):789-92. PubMed ID: 15545879
[TBL] [Abstract][Full Text] [Related]
20. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Aydin A; Yu JQ; Zhuang H; Alavi A
Clin Nucl Med; 2005 Sep; 30(9):606-7. PubMed ID: 16100478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
